ASCO

ASCO: Alcohol Is A Modifiable Risk Factor for Cancer

ASCO: Alcohol Is A Modifiable Risk Factor for Cancer

By

Seventy percent of Americans surveyed in this year's National Cancer Opinion Survey were unaware that alcohol is a well-established and modifiable risk factor for cancer, the authors noted.

ASCO: CAR T-Cell Therapy Promising for Multiple Myeloma

ASCO: CAR T-Cell Therapy Promising for Multiple Myeloma

Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein demonstrated promising results.

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

By

ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.

ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention

ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention

By

ASCO offers global recommendations for HPV vaccination tailored to structural resource levels of regions.

ONS Partners with ASCO CancerLinQ to Launch CancerLinQ® Ambassadors Program

ONS Partners with ASCO CancerLinQ to Launch CancerLinQ® Ambassadors Program

By

CancerLinQ® Ambassadors Program is launched to provide support and guidance to practices participating in CancerLinQ®.

ASCO Issues Adjuvant Bisphosphonate in Breast Cancer Guideline

ASCO Issues Adjuvant Bisphosphonate in Breast Cancer Guideline

By

Zoledronic acid and clodranate are the recommended bisphosphonates for the adjuvant treatment of postmenopausal patients with breast cancer.

ASCO Endorses ACS Head and Neck Survivorship Care Guideline

ASCO Endorses ACS Head and Neck Survivorship Care Guideline

By

ASCO endorses ACS head and neck survivorship care guideline, which supports health promotion, especially regarding tobacco cessation and dental care.

Nurse-Calling Program Improves Retention Rates From First Treatment Visit

Nurse-Calling Program Improves Retention Rates From First Treatment Visit

By

Patients who speak to an oncology nurse prior to their first appointment are significantly more likely to be retained for their treatment.

Hematologic Oral Chemotherapy Clinic Reduces Emergency Department Visits

Hematologic Oral Chemotherapy Clinic Reduces Emergency Department Visits

By

A hematologic multidisciplinary oral chemotherapy clinic established at a community hospital identified adverse events early and reduced ED visits.

Study Assesses Risk of Secondary AML in Patients With Myeloproliferative Neoplasms

Study Assesses Risk of Secondary AML in Patients With Myeloproliferative Neoplasms

By

Among patients with myeloproliferative neoplasms, men with primary myelofibrosis diagnosed after 2006 are at the highest risk of developing secondary acute myeloid leukemia (AML).

ASCO Updates the Development Process for Its Clinical Practice Guidelines

ASCO Updates the Development Process for Its Clinical Practice Guidelines

By

ASCO has laid out a game plan to set the stage for incorporating new therapies and approaches into clinical guidelines as quickly and accurately as possible.

ASCO: Smartphone App May Help Lung Cancer Patients Live Longer

ASCO: Smartphone App May Help Lung Cancer Patients Live Longer

Researchers found tracking symptoms and alerting doctors to problems early led to longer survival for patients with lung cancer.

ASCO Releases Resource-Stratified Guidelines for Management of Invasive Cervical Cancer

ASCO Releases Resource-Stratified Guidelines for Management of Invasive Cervical Cancer

By

ASCO has published its first clinical practice guideline on invasive cervical cancer, and the guidelines are the first to offer treatment recommendations tailored to resource availability.

ASCO: Aggressive Treatment Common in Terminal Cancer Patients

ASCO: Aggressive Treatment Common in Terminal Cancer Patients

Three in four of young or middle-aged patients with terminal cancer receive aggressive therapies in their last months of life.

ASCO Develops Care Recommendations for Invasive Cervical Cancer

ASCO Develops Care Recommendations for Invasive Cervical Cancer

The American Society for Clinical Oncology has developed guidelines for the management and palliative care of women diagnosed with invasive cervical cancer.

ASCO Statement Seeks to Balance Prescription Opioids for Patients With Cancer and Misuse and Abuse Prevention

ASCO Statement Seeks to Balance Prescription Opioids for Patients With Cancer and Misuse and Abuse Prevention

By

ASCO addresses the complex issues surrounding prescription opioids in a new policy statement. ASCO supports the efforts of multiple federal offices and agencies to prevent and respond to prescription drug abuse, and is also working to protect access to appropriate medical opioid therapy for patients with cancer.

ASCO Offers Guidelines for Increasing HPV Vaccine Uptake

ASCO Offers Guidelines for Increasing HPV Vaccine Uptake

Oncologists should raise awareness of HPV-related cancers and role of vaccinations

ASCO Endorses European Association of Urology Guideline on Bladder Cancer

ASCO Endorses European Association of Urology Guideline on Bladder Cancer

Guideline on muscle-invasive and metastatic bladder cancer, with qualifying statements

New Guideline from ASCO Addresses Use of Biomarkers for Early Breast Cancer

By

A new clinical practice guideline on the appropriate use of tests for breast tumor biomarkers was issued by ASCO.

ASTRO guidelines for endometrial cancer endorsed by ASCO

ASTRO guidelines for endometrial cancer endorsed by ASCO

Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.

Immunotherapy combination increases progression-free survival (PFS) in advanced melanoma patients

By

Treating advanced melanoma patients with either a combination of nivolumab and ipilimumab, or nivolumab alone, significantly increases progression-free survival (PFS) when compared with ipilimumab alone.

ASCO: Elotuzumab demonstrates benefit in multiple myeloma

ASCO: Elotuzumab demonstrates benefit in multiple myeloma

Survival gains observed when elotuzumab was added to treatment.

ASCO: Additional tissue removal reduces further breast cancer surgery

ASCO: Additional tissue removal reduces further breast cancer surgery

Removing extra tissue can halve the chances of requiring a second surgery in breast cancer.

ASCO: Lymph node surgery not best option for all melanoma patients

ASCO: Lymph node surgery not best option for all melanoma patients

For some patients with advanced melanoma, surgical removal of the lymph nodes surrounding their tumor may not be needed.

ASCO: PD-1 immunotherapy beneficial for patients with NSCLC

ASCO: PD-1 immunotherapy beneficial for patients with NSCLC

Fewer side effects, longer survival for nivolumab versus docetaxel seen in patients with non-small-cell lung cancer (NSCLC).

Hepatitis virus variations responsible for variations in liver cancer

By

Significant clinical variations have been identified among patients with hepatocellular carcinoma (HCC).

ASCO: Nicotinamide could help prevent non-melanoma skin cancer

ASCO: Nicotinamide could help prevent non-melanoma skin cancer

A preliminary Australian study saw association between nicotinamide and lower rates of non-melanoma skin cancers.

ASCO: High-risk prostate cancer diagnosis up since new PSA recommendations

ASCO: High-risk prostate cancer diagnosis up since new PSA recommendations

Researchers report 3 percent annual rise in intermediate- and high-risk cases

ASCO: Active surveillance for prostate cancer may decrease survival odds for some

ASCO: Active surveillance for prostate cancer may decrease survival odds for some

When active surveillance is chosen, survival for intermediate-risk disease may be decreased.

ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer

ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer

Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs